Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.\new Filed Acc 0001144204-08-044464

Options or other derivatives

  • Chief Executive Officer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Katz Burton · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2008-02-04 Grant or award : show line 1 in the form Stock Option (Right to Buy) +300,000 300,000 D
Loading xslF345X03/v102280_ex.xml…